CFO moves, week of July 27 – August 2, 2026

The week in numbers

SEC filings logged 17 CFO moves for the week of July 27–August 2, 2026. Departures were the most common event type at 8, followed by 6 transitions, 2 appointments, and 1 interim designation. Of the 9 seats filled, 5 were external hires, 3 were internal promotions, and the origin of 1 incoming CFO was not established. The interim share for the week stood at 5.9%. Among incoming CFOs where it could be determined, 3 had prior CFO experience and the figure was not established for 6. No incoming CFO was identified as a first-time CFO. Median tenure at departure could not be calculated because none of the 8 departing CFOs had a known tenure on record.

Notable moves

Biological Products and Pharmaceutical Preparations each accounted for 2 moves, making life sciences the most active area of the week. Precision BioSciences, Inc. filed a transition with Naresh Tanna replacing Alex Kelly, effective August 1. Yarrow Bioscience, Inc. filed a transition with Tyler Zeronda replacing Mutya Harsch, effective July 27. Quince Therapeutics, Inc. appointed John Militello, with no effective date stated.

Among the longer-dated changes, Lemonade, Inc. filed a transition with Nick Stead set to replace Tim Bixby on January 1, 2027, and Tennant Company disclosed the departure of Fay West with an effective date of April 2, 2027. Owens Corning filed a transition with Jonathan M. Collins replacing Todd W. Fister on August 10. ZipRecruiter, Inc. disclosed Carmen Chan replacing David Travers effective August 17.

For Sonos, Inc. and Cabot Corporation, effective dates for the departures of Saori Casey and Erica McLaughlin, respectively, were not stated. Olenox Industries Inc. named Kimberly Hawley interim CFO, effective July 6. 2 moves came from sectors not on the standard roster.